RT Journal Article
T1 Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia.
A1 Sanz-Cánovas, Jaime
A1 López-Sampalo, Almudena
A1 Cobos-Palacios, Lidia
A1 Ricci, Michele
A1 Hernández-Negrín, Halbert
A1 Mancebo-Sevilla, Juan José
A1 Álvarez-Recio, Elena
A1 López-Carmona, María Dolores
A1 Pérez-Belmonte, Luis Miguel
A1 Gómez-Huelgas, Ricardo
A1 Bernal-López, Maria Rosa
K1 elderly
K1 frailty
K1 sarcopenia
K1 type 2 diabetes mellitus
AB The life expectancy of the population is increasing worldwide due to improvements in the prevention, diagnosis, and treatment of diseases. This favors a higher prevalence of type 2 diabetes mellitus (T2DM) in the elderly. Sarcopenia and frailty are also frequently present in aging. These three entities share common mechanisms such as insulin resistance, chronic inflammation, and mitochondrial dysfunction. The coexistence of these situations worsens the prognosis of elderly patients. In this paper, we review the main measures for the prevention and management of sarcopenia and/or frailty in elderly patients with T2DM.
YR 2022
FD 2022-07-16
LK http://hdl.handle.net/10668/21084
UL http://hdl.handle.net/10668/21084
LA en
DS RISalud
RD Apr 10, 2025